Piramal Pharma Limited

NSE: PPLPHARMA BSE: 543635 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

212 3(-1%)

Near 52W High of 220

Volume

25L as on 03, Sep

Open

209

High

256

Low

250

214

VWAP

214

52 Week High

220

52 Week Low

132

Viand Research Rating

Quality Score

5/100

Growth Score

18/100

Valuation Score

50/100

Momentum Score

70/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

28,186

No. of Shares

133

P/E

50.66

P/B

4.64

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

9.16

ROCE

Profit Growth

Listing Date

19-Oct-22

Promoter Holding

34.85%

FII Holding

30.17%

DII Holding

15.61%

Price Chart

Price Performance

1 Week0%

1 Month8%

3 Months28%

6 Months40%

1 Year8%

YTD26%

Moving Average

5 Day SMA215

10 Day SMA213

20 Day SMA212

30 Day SMA207

50 Day SMA194

61 Day SMA188

80 Day SMA185

200 Day SMA172

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	224	216	221	225
Resistance 2	221	215	218	221
Resistance 1	217	214	217	218
Pivot Point	214	214	214	215
Support 1	211	213	212	212
Support 2	208	213	210	208
Support 3	204	212	208	205

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022
Promoters	(0.01) 34.85%	(0.01) 34.85%	(0.01) 34.85%	(-0.11) 34.85%	(0.01) 34.94%	(0.01) 34.94%	(0.01) 34.94%	(-0.11) 34.94%	(0.01) 35.02%	(0.01) 35.02%	(0.21) 35.02%	(0.01) 34.78%	(0.01) 34.78%	(0.01) 34.78%
FIIs	(0.51) 30.17%	(-0.61) 29.66%	(-0.61) 30.27%	(-0.61) 30.86%	(-0.21) 31.49%	(-0.11) 31.68%	(0.31) 31.73%	(0.81) 31.41%	(-1.91) 30.58%	(0.11) 32.51%	(-2.61) 32.37%	(-4.31) 35.01%	(-2.01) 39.28%	(0.01) 41.29%
DIIs	(-0.11) 15.61%	(0.81) 15.68%	(0.61) 14.89%	(-0.51) 14.25%	(0.71) 14.78%	(0.31) 14.09%	(0.91) 13.80%	(0.81) 12.95%	(2.41) 12.12%	(1.71) 9.68%	(2.51) 8.01%	(0.51) 5.48%	(-0.31) 4.98%	(0.01) 5.26%
Public	19.01%	19.35%	19.46%	19.46%	18.42%	18.85%	19.06%	20.20%	21.89%	22.41%	24.21%	24.32%	20.57%	18.27%
No. of Shareholders	450,661	453,830	462,511	458,430	432,843	418,442	359,751	306,398	297,996	292,312	300,606	277,270	241,359	229,960

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	2751.77	2139.87	2043.72	1933.71	2754.07	2204.22	2241.75	1951.14	2552.36	1958.57	1911.38	1748.85	2163.58	1716	1720	1482	2131	1539.12	1578
Sales Growth % (YoY)	-0.1%	-2.9%	-8.8%	-0.9%	7.9%	12.5%	17.3%	11.6%	18%	14.1%	11.1%	18%	1.5%	11.5%	9%	-	-	-	-
Sales Growth % (QoQ)	28.6%	4.7%	5.7%	-29.8%	24.9%	-1.7%	14.9%	-23.6%	30.3%	2.5%	9.3%	-19.2%	26.1%	-0.2%	16.1%	-30.5%	38.5%	-2.5%	-
Expenses	2291.26	1944.14	1885.03	1827.01	2193.08	1866.48	1900.14	1746.65	2022.43	1690.2	1645.74	1616.53	1812.31	1629	1547	1465	1733	1313.53	1381
Operating Profit	460.51	195.73	158.69	106.7	560.99	337.74	341.61	204.49	529.93	268.37	265.64	132.32	351.27	87	173	17	398	225.59	197
OPM %	16.74	9.15	7.76	5.52	20.37	15.32	15.24	10.48	20.76	13.7	13.9	7.57	16.24	5	10	1	19	14.66	12
Other Income	-116.14	12.39	80.39	97.71	58.25	29.18	78.37	41.94	7.9	43.19	68.3	52.7	32.28	98	50	92	97	169.74	34
Interest	82.99	89.24	82.42	86.15	103.68	103.31	107.64	106.96	114.22	105.88	109.87	118.52	104.25	95	83	62	57	50.13	49
Depreciation	218.38	212.74	202.84	197.28	242.76	196.81	192.22	184.55	196.13	186.32	184.51	173.61	184.41	164	166	162	165	147.15	138
Profit before tax	43	-93.86	-46.18	-79.02	272.8	66.8	120.12	-45.08	227.48	19.36	39.56	-107.11	94.89	-74	-26	-115	273	198.05	44
Tax %	120.53	45.1	114.85	3.39	43.73	94.49	81.19	96.63	55.48	47.78	87.31	-7.96	47.19	22	42	-5	25	17.51	16
Net Profit	-8.83	-136.19	-99.22	-81.7	153.5	3.68	22.59	-88.64	101.27	10.11	5.02	-98.58	50.11	-90	-37	-109	204	163.37	37
Net Profit Growth % (QoQ)	93.5%	-37.3%	-21.4%	-153.2%	4071.2%	-83.7%	125.5%	-187.5%	901.7%	101.4%	105.1%	-296.7%	155.7%	-143.2%	66.1%	-153.4%	24.9%	341.5%	-
Net Profit Growth % (YoY)	-105.8%	-3800.8%	-539.2%	7.8%	51.6%	-63.6%	350%	10.1%	102.1%	111.2%	113.6%	9.6%	-75.4%	-155.1%	-200%	-	-	-	-
TTM Net Profit	-325.94	-163.61	-23.74	98.07	91.13	38.9	45.33	27.76	17.82	-33.34	-133.45	-175.47	-185.89	-32	221.37	295.37	404.37	200.37	0
EPS in Rs	-0.07	-1.02	-0.75	-0.61	1.16	0.03	0.17	-0.67	0.77	0.08	0.04	-0.75	0.38	-0.68	-0.28	0	0	0	0

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Sales	8869	9151	8171	7082	6559	6315
Sales Growth %	-3.1%	12%	15.4%	8%	3.9%	-
Expenses	7947	7706	6974	6453	5609	4887
Operating Profit	922	1445	1197	629	950	1428
OPM %	10	16	15	9	14	23
Other Income	74	208	172	272	319	230
Interest	341	422	448	344	198	163
Depreciation	831	816	741	677	586	545
Profit before tax	-176	415	179	-120	485	949
Tax %	85	78	90	55	22	12
Net Profit	-326	91	18	-186	376	835
Net Profit Growth %	-458.2%	405.6%	109.7%	-149.5%	-55%	-
EPS in Rs	-2.45	0.69	0.13	-1.41	0	0
Dividend Payout %	0	20	82	0	18	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Cash from Operating Activity	1653	892	1005	484	766	598
Cash from Investing Activity	-826	-488	-416	-1334	-1737	-4464
Cash from Financing Activity	-39	-441	-422	818	794	3977
Net Cash Flow	788	-37	166	-32	-177	110

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Equity Capital	1327	1326	1324	1323	1323	1193	1186	995
Reserves	6835	6748	6801	6584	6588	5580	5511	4610
Borrowings	5675	4851	4856	4786	4710	5637	4128	3025
Other Liabilities	4128	3265	2447	2548	2461	1893	1781	2047
Total Liabilities	17965	16189	15429	15242	15083	14303	12605	10677
Fixed Assets	8985	8827	8133	8475	7990	7469	6879	6105
CWIP	799	567	977	621	1116	1419	1172	627
Investments	437	442	291	241	385	639	267	123
Other Assets	7744	6353	6028	5905	5592	4777	4286	3822
Total Assets	17965	16189	15429	15242	15083	14303	12605	10677

Delivery

Delivery Data: PPLPHARMA

#	Date	165 33% 220	Value (Cr)	Q/T 124	Del 35	Del 100
1	4-Sep	214	56	95	39	22
2	3-Sep	214	54	78	37	20
3	2-Sep	214	66	103	40	27
4	1-Sep	213	67	116	33	22
5	31-Aug	214	57	106	42	24
6	28-Aug	219	118	113	42	49
7	27-Aug	215	100	89	43	43
8	26-Aug	211	57	73	47	26
9	25-Aug	208	36	77	32	11
10	24-Aug	211	57	74	48	27
11	21-Aug	214	99	103	49	48
12	20-Aug	217	89	93	50	44
13	19-Aug	210	61	110	32	20
14	18-Aug	211	111	96	33	37
15	17-Aug	205	60	108	37	22
16	14-Aug	207	239	134	18	43
17	13-Aug	213	48	93	39	18
18	12-Aug	210	58	103	38	22
19	11-Aug	214	79	106	42	33
20	10-Aug	214	194	122	37	72
21	7-Aug	210	97	125	47	45
22	6-Aug	208	150	105	40	60
23	5-Aug	207	192	174	51	98
24	4-Aug	202	141	124	37	52
25	3-Aug	199	141	111	35	50
26	31-Jul	196	131	121	32	42
27	30-Jul	197	440	112	27	120
28	29-Jul	196	233	94	46	107
29	28-Jul	193	138	123	41	56
30	27-Jul	192	288	141	41	119
31	24-Jul	181	70	118	40	28
32	23-Jul	181	163	131	30	48
33	22-Jul	177	158	126	41	65
34	21-Jul	185	180	143	41	73
35	20-Jul	179	75	122	39	29
36	17-Jul	179	119	147	47	56
37	16-Jul	175	83	109	32	26
38	15-Jul	172	36	98	35	13
39	14-Jul	172	47	102	39	18
40	13-Jul	174	68	93	46	32
41	10-Jul	177	94	121	46	43
42	9-Jul	172	136	140	32	44
43	8-Jul	168	120	133	40	48
44	7-Jul	175	90	117	45	40
45	6-Jul	178	180	154	34	62
46	3-Jul	176	589	170	32	189
47	2-Jul	168	76	110	46	35
48	1-Jul	169	80	102	36	29
49	30-Jun	168	68	112	42	29
50	29-Jun	167	59	92	29	17

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	28,186c	385c	1.35
31-Aug	28,571c	200c	0.70
26-Aug	28,371c	719c	2.60
25-Aug	27,652c	573c	2.03
24-Aug	28,225c	635c	2.20
21-Aug	28,860c	961c	3.45
19-Aug	27,898c	113c	0.40
18-Aug	28,012c	755c	2.77
17-Aug	27,257c	469c	1.69
14-Aug	27,725c	590c	2.08
13-Aug	28,315c	437c	1.57
12-Aug	27,878c	807c	2.81
11-Aug	28,685c	156c	0.55
10-Aug	28,530c	766c	2.76
06-Aug	27,764c	1,383c	5.24
04-Aug	26,381c	421c	1.62
31-Jul	25,960c	433c	1.64
30-Jul	26,393c	442c	1.70
29-Jul	25,951c	209c	0.81
28-Jul	25,742c	180c	0.70
27-Jul	25,562c	0	0

Stock Checklist

Price is above from 52 week high low average: 90%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 168 fund scheme(s) across 25 fund house(s) as of Aug26 · Total value ₹6,805 Cr · 121 increasing / 18 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
HDFC Mutual Fund	12	1.05%	-0.04%	3165.2
Nippon India Mutual Fund	12	0.37%	+1.20%	770.9
Canara Robeco Mutual Fund	8	0.79%	+0.30%	626.3
Franklin Templeton Mutual Fund	6	0.90%	+0.19%	518.5
Bajaj Finserv Mutual Fund	10	1.62%	+0.39%	455.1
ICICI Prudential Mutual Fund	16	0.45%	+0.12%	354.1
Bandhan Mutual Fund	8	0.59%	-0.05%	334
Axis Mutual Fund	22	0.38%	+0.37%	207.8
LIC Mutual Fund	10	1.78%	+0.22%	82.2
Aditya Birla Sun Life Mutual Fund	10	0.37%	+0.16%	75
Helios Mutual Fund	4	0.83%	-0.19%	50.2
ICICI Prudential Asset Management Company Limited	1	0.46%	+0.15%	44
Kotak Mahindra Mutual Fund	6	0.13%	+0.04%	41.9
Tata Mutual Fund	6	0.72%	+0.09%	24.7
SBI Mutual Fund	4	0.41%	+0.06%	20.5
Motilal Oswal Mutual Fund	8	0.22%	+0.06%	19.7
ITI Mutual Fund	2	1.27%	+0.13%	6.7
Edelweiss Mutual Fund	2	0.56%	+0.07%	3
Jio BlackRock Mutual Fund	2	0.43%	+0.07%	2.4
Groww Mutual Fund	4	0.19%	+0.06%	2
DSP Mutual Fund	6	0.66%	+0.17%	0.7
Navi Mutual Fund	4	0.13%	-0.01%	0.1
Angel One Mutual Fund	2	0.06%	+0.01%	0.1
Mirae Asset Mutual Fund	2	0.06%	-	0.1
Zerodha Mutual Fund	1	0.30%	-	0

Piramal Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements